Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study.
D001241:Aspirin / Q000627:therapeutic use*; D002170:Canada; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D008297:Male; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D001241:Aspirin; D013442:Sulfinpyrazone